Salarius Pharmaceuticals Stock Forecast

Sell candidate since Jul 08, 2026 Loss -16.00%

The Salarius Pharmaceuticals, Inc. stock price fell by -2.23% on the last day (Friday, 24th Jul 2026) from $4.94 to $4.83. During the last trading day the stock fluctuated 12.08% from a day low at $4.80 to a day high of $5.38. The price has fallen in 8 of the last 10 days and is down by -18.27% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 9 thousand shares were bought and sold for approximately $44.29 thousand.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $4.51 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Salarius Pharmaceuticals, Inc. stock with a 90% probability to be traded between $4.57 and $9.75 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

DCOY Signals & Forecast

There are few to no technical positive signals at the moment. The Salarius Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.22 and $6.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -49.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Salarius Pharmaceuticals, Inc. stock

Salarius Pharmaceuticals, Inc. finds support from accumulated volume at $4.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.580 between high and low, or 12.08%. For the last week the stock has had daily average volatility of 9.63%.

Salarius Pharmaceuticals, Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DCOY) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Salarius Pharmaceuticals, Inc. to open at $5.00, and during the day (based on 14 day Average True Range), to move between $4.41 and $5.25, which gives a possible trading interval of +/-$0.84 (+/-18.95%) up or down from last closing price. If Salarius Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 18.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.82 (0.21%) than the resistance at $5.51 (14.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Salarius Pharmaceuticals, Inc. stock A Buy?

Salarius Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.438 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $5.00 ( 3.59%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk